All News

Pfizer snags fourth indication for blockbuster Xeljanz

September 29, 2020

Pfizer snagged its fourth indication for the blockbuster medication tofacitinib (Xeljanz) for children and adolescents 2 years and older with active polyarticular course juvenile idiopathic arthritis (pcJIA).

FDA requires new boxed warning on benzodiazepines

September 29, 2020

Xanax and Ativan are among the medications impacted by FDA’s new requirements.

Sun Pharma Recalls 1 Lot of Metformin Due to NDMA Levels

September 28, 2020

Sun Pharmaceuticals issued a voluntary recall of 1 lot of its metformin hydrochloride for extended-release (ER) oral suspension (Riomet ER), 500 mg per 5 mL.

Top 5 drugs in the pipeline

September 22, 2020

Some of the top medications were approved this summer, while others are awaiting FDA approval.

Major thyroid med recall underway

September 22, 2020

Both recalls are due to sub-potency of drugs that treat hypothyroidism.

Jardiance to get new heart attack prevention indication

September 15, 2020

The top-selling diabetes drug will join semaglutide (Ozempic), which is approved to reduce the risk of major adverse cardiovascular events.

Carcinoma med snags Breakthrough Therapy Designation

September 14, 2020

The treatment is the first anti-PD-1 antibody from China to receive Breakthrough therapy designation.

Lung cancer's new drug based on precision medicine

September 08, 2020

Pharma makers expect the treatment to be available within a week.

FDA clears oral leukemia drug

September 08, 2020

The medication boasts a statistically significant improvement in overall survival versus placebo.

FDA expands emergency use authorization for remdesivir to include all hospitalized COVID-19 patients

August 31, 2020

One study questions the effectiveness of remdesivir past day 10 while others support its expanded use.